Merck & Co Inc (NYSE: MRK) has reported E.P.S. of $2.14 for its second fiscal quarter (ending June 30) versus $-2.35 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $5.41 compared to $1.22 a year ago.
Recent Price Action
Merck & Co Inc (NYSE: MRK) stock suffered a large decline of -9.8% on 7/30/24. The stock closed at $115.25. Moreover, this decline was accompanied by exceptionally high trading volume at 379% of normal. Relative to the market the stock has been strong over the last nine months but has declined -8.3% during the last week.
Current PriceTarget Research Rating
MRK is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Merck has a current Value Trend Rating of B (Positive). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Merck has a slightly positive Appreciation Score of 61 and a good Power Rating of 80, producing the Positive Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment